US Patent Issued to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION on Feb. 17 for "Pharmaceutical composition for preventing or treating dengue fever" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,494, issued on Feb. 17, was assigned to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (Seoul, South Korea).

"Pharmaceutical composition for preventing or treating dengue fever" was invented by Dal Hee Min (Seoul, South Korea) and Ho Jeong Shin (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition including a compound of Formula 1 may be used for preventing or treating dengue fever. Specifically, the composition may include ulipristal, ulipristal acetate, or a pharmaceutically acceptable salt thereof, which may inhibit dengue virus infection. The dengue fever may be caused by infection with dengue virus DENV-1, D...